In suspected metastatic breast cancer, tissue biopsy confirms diagnosis, updates receptor status, guides targeted therapy, prevents misclassification, enables trial access, and supports timely, personalized treatment decisions.

A new biopsychosocial risk score predicts persistent, widespread, or high-impact chronic pain, enabling earlier personalized care, safer prescribing, and better health system planning for vulnerable patients.

Emerging evidence suggests menopausal hormone therapy enhances tirzepatide-driven weight loss in postmenopausal women, offering a synergistic, hormone-informed approach to obesity, metabolic risk reduction, and healthier aging.

Polycystic ovary syndrome requires individualized, stepwise care addressing menstrual irregularity, androgen symptoms, fertility goals, metabolic risk, and mental health through long-term, coordinated multidisciplinary management.

A large Swedish study finds COVID-19 vaccination does not reduce fertility or childbirth rates, providing strong evidence to counter misinformation and reassure women and healthcare providers worldwide.

Early-life exposure to air pollution and household dampness increases childhood asthma risk by altering lung development and immunity, highlighting urgent needs for cleaner air and healthier housing.

A large study finds U.S. mothers experience persistent postpartum depression without recovery, highlighting systemic failures in paid leave, childcare, and healthcare compared with the UK and Australia.

Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.

Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.